FDA.reportPublic FDA data

emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet

RxCUI
1747691
RxNorm name
emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet
Display name
emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet
Full name
emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DESCOVYEMTRICITABINE AND TENOFOVIR ALAFENAMIDEGilead Sciences, Inc.06f66e98-e6ee-4538-9506-6c1282cc14c12026-07-07Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1747691

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
06f66e98-e6ee-4538-9506-6c1282cc14c1emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [PSN] · emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [SCD]212These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY ® (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 201520250620